Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carotuximab + Pazopanib in Advanced Soft Tissue Sarcoma
NCT01975519Phase 2Completed
- Sponsor
- TRACON Pharmaceuticals, Inc.
- Start
- Dec 2013
- Primary completion
- Mar 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of carotuximab in soft tissue sarcoma (STS), angiosarcoma, sponsored by TRACON Pharmaceuticals, Inc.. Started Dec 2013; status: completed.
02
Drugs
carotuximab
03
Conditions
soft tissue sarcoma (STS)angiosarcoma
Beyond the preview
Go deeper on NCT01975519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975519.